Welcome to the CIBMTR Forms Instruction Manual. The Table of Contents on the left side of the screen is for navigational purposes; if you are on a mobile device you may find the Table on Contents on the top of the page.
General Instructions provides useful general background information for successfully completing forms.
2804/2814: CRID Assignment and Indication provides explanatory text used to generate a CIBMTR Research ID (CRID) and report the indication.
Transplant Essential Data (TED) Manuals provides explanatory text for each question found on the TED forms.
Comprehensive Baseline & Follow-up Forms Manuals provides explanatory text for each question on the Baseline, Follow-up, IDMs, HLA, and Infusion forms.
Comprehensive Disease Specific Manuals provides explanatory text and additional information for disease indications requiring CIBMTR reporting.
Cellular Therapy Manuals provides explanatory text for completing pre-infusion, infusion, and post-infusion forms
Infection & Miscellaneous Manuals provides explanatory text for manuals such as the Hepatitis Serology, VOD / SOS, and Myelofibrosis CMS Study forms.
Appendices provide additional information beyond the scope of the other manuals.
Sections of the Forms Instruction Manual are frequently updated. In addition to documenting the changes within each manual section, the most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.
|8/29/2019||“4006: Product Identification”||Modify|| Updated instruction in pink warning box above question 17: Question 17-45: Reporting total number of cells
Report the total number of cells (not cells per kilogram) contained in the product administered
|8/14/2019||4000: Cellular Therapy and HCT History||Modify||Updated instruction for question 24: If “yes”, continue to question 29. If “no”, continue with question 25. If “unknown”, questions 25, 26, and 28 are optional and you can continue to question 23.|
|8/14/2019||4000: Cellular Therapy and HCT History||Modify||Updated instruction for question 15: If “yes”, continue to question 23. If “no”, continue with question 16. If “unknown”, questions 16, 17, 18, and 22 are optional and you can continue to question 23.|
|8/2/19||2820: Recipient Contact Information||Modify||Version 2 of the 2820: Recipient Contact Information section of the Forms Instructions Manual released. Version 2 corresponds to revision 2 of the Form 2820.|
|7/3/19||2400: Pre-TED||Modify|| Updated (new text in red and removed text
A HLA-haploidentical donor is one who shares, by common inheritance, exactly one HLA haplotype with the recipient and is mismatched for a variable number of HLA genes, ranging from
|6/27/19||4006: Cellular Therapy Infusion||Modify||Added additional information to the manual providing specific reporting instructions for commercially available products.|
|6/27/19||4003: Cellular Therapy Product||Modify||Added additional information to the manual providing specific reporting instructions for commercially available products.|
|6/27/19||4000: Cellular Therapy Essential Data Pre-Infusion||Modify||Added additional information to the manual providing specific reporting instructions for commercially available products.|
|6/17/19||2400: Pre-TED||Modify|| Added additional information (in red below) to the instructional text for question 40 to better define the related donor types listed on the form:
Indicate the relationship and match between the recipient and the donor. Only consider HLA-A, B, C, and DRB1 when determining the donor’s match / mismatched relationship to the recipient.
|5/14/2019||F4100 Cellular Therapy Essential Data Follow-up||Remove|| Removed note box